Article Sidebar
Published:
Feb 11, 2025Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Balloon dilation of Eustachian tube combined with triamcinolone acetonide therapy for secretory otitis media
Abstract
Purpose: To determine the effect of combining Eustachian tube balloon dilatation with triamcinolone
acetonide on inflammatory response and immune function in secretory otitis media patients.
Methods: Seventy-six (76) patients diagnosed with acute secretory otitis media in the Ninth People's
Hospital Affiliated with Shanghai Jiao Tong University, Shanghai, China were randomly assigned to
study group (SG) and control group (CG). Patients in CG received 40 mg triamcinolone acetonide
injections in the tympanic membrane weekly for 4 weeks, while SG patients were administered
Eustachian tube balloon dilatation in addition to triamcinolone acetonide injection. Pre- and posttreatment
assessments in the two evaluated groups included the proportion of T lymphocytes, serum
inflammatory molecules and Eustachian Tube Score (ETS).
Results: The study group exhibited a significantly higher efficacy (92.1 %) than the control group (68.4
%; p < 0.05). In addition, the study group exhibited higher CD8+, CD4+, CD4+/CD8+ ratio and T cells
proportion after treatment (p < 0.05). Furthermore, the concentration of serum inflammatory cytokines
(PCT, IL-2, IL-4, TNF-α) in SG was significantly lower than that in CG (p < 0.05). Also, the ETS score in
CG was lower (3.53 ± 2.40) compared to SG (5.25 ± 2.02) after treatment (p < 0.05).
Conclusion: The combination of triamcinolone acetonide and Eustachian tube balloon dilation
demonstrates enhanced efficacy in alleviating symptoms, diminishing inflammatory responses and reestablishing
immune balance in the treatment of acute secretory otitis media, underscoring its significant
promise. Longer follow-up and larger sample size prospective studies are, however, warranted.
Keywords:
